S-phase cyclins are required for a stable arrest at metaphase  by Meyn III, Malcolm A. & Holloway, Sandra L.
Brief Communication 1599
S-phase cyclins are required for a stable arrest at metaphase
Malcolm A. Meyn III and Sandra L. Holloway
A critical DNA damage checkpoint in Saccharomyces
cerevisiae is an arrest at the metaphase stage of
mitosis. Here we show that the S-phase cyclins Clb5
and Clb6 are required for this arrest. Strains lacking
Clb5 and Clb6 are hypersensitive to DNA damage.
Furthermore, in the presence of the DNA alkylating
agent methyl methanesulfonate (MMS) over 50% of
clb5 clb6 mutants by-passed the metaphase checkpoint
and arrested instead with separated sister chromatids.
Levels of Pds1, an inhibitor of anaphase that
accumulates following DNA damage, were similar in the
wild-type and mutant strains following MMS treatment.
Furthermore, unlike wild-type cells, clb5 clb6 mutants
undergo nuclear division despite the presence of
nuclear non-degradable Pds1. Our results suggest a
novel role for the S-phase cyclins Clb5 and Clb6 in
maintaining sister chromatid cohesion during a
metaphase arrest, perhaps by regulating Pds1 activity. 
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Results and discussion
To determine whether Clb5 is required for the DNA
damage response we tested clb5 deletion mutants for sen-
sitivity to MMS. Survival curve analysis showed that these
mutants were more sensitive to MMS treatment than the
isogenic wild-type strain (Figure 1a). We also tested the
MMS sensitivity of strains deleted for the CLB5 homo-
logue CLB6. Deletion of CLB6 by itself did not increase
MMS sensitivity. clb5 clb6 double mutants, however,
showed an MMS sensitivity greater than that of the clb5
mutants, suggesting that Clb5 and Clb6 function together
during the DNA damage response. The clb5 clb6 mutants
were also hypersensitive to UV and ionizing radiation
(data not shown). None of the mutants tested were as sen-
sitive to any treatment as the DNA damage checkpoint
mutant mec1 (Figure 1a, and data not shown) [1]. To
confirm that the observed increase in MMS sensitivity was
indeed due to the absence of Clb5, clb5 clb6 mutants were
transformed with a centromeric plasmid containing CLB5.
The MMS sensitivity of this strain was restored to wild-
type levels (Figure 1b). Together, these results provide
evidence that Clb5 and Clb6 are required for the DNA
damage response of S. cerevisiae. 
Strains lacking CLB5 and CLB6 delay the initiation of DNA
replication, resulting in an increase in the proportion of the
cell cycle spent with a G1 DNA content [2]. Cells with a
1C DNA content are unable to repair DNA damage using
homologous sequences and as a result are more sensitive to
DNA damage. It is possible, therefore, that the increase in
MMS sensitivity observed for the clb5 clb6 mutants was an
artifact of the delayed onset of DNA replication in this
strain. To rule out this explanation for the MMS sensitivity
of clb5 clb6 mutants, we repeated the assay in diploid
strains. clb5/clb5 clb6/clb6 diploid mutants were significantly
more sensitive to MMS than the isogenic wild-type strain
(Figure 1c). Like the haploid mutants, the sensitivity of the
clb5/clb5 clb6/clb6 mutants could be restored to wild-type
levels of MMS sensitivity by introduction of CLB5 on a
centromeric plasmid (Figure 1c). These results indicate
that the increase in MMS sensitivity of clb5 and clb5 clb6
mutants is caused by disrupting the DNA damage response
pathway, rather than being an artifact of alteration of the
timing of DNA replication in these strains.
Increased sensitivity to DNA damage can be caused by
either a failure to repair damaged DNA or a failure to
arrest in response to DNA damage [3]. To distinguish
between these two defects we tested whether we could
rescue the DNA-damage-induced lethality of clb5 clb6
mutants with an artificial metaphase arrest [4]. If Clb5 is
part of a checkpoint pathway that arrests cells in response
to DNA damage, then an artificial arrest should rescue clb5
clb6 mutants exposed to MMS. The MMS sensitivity of
clb5 clb6 mutants was significantly decreased when cells
were treated with nocodazole to induce spindle damage
and activate a metaphase arrest before MMS treatment
(Figure 1d). The increased resistance of clb5 clb6 mutants
to MMS when held in nocodazole was not due to the
fact that these cells have replicated their DNA because
diploid clb5 clb6 mutants are still supersensitive to MMS
(Figure 1c). This result supports a primary function for
Clb5 and Clb6 in the DNA damage checkpoint pathway.
Viability was not restored to wild-type levels, however.
This may reflect a partial role for Clb5 and Clb6 in DNA
repair or some sensitivity of this strain to the nocodazole
treatment itself. 
DNA damage activates a checkpoint pathway that slows
progression through S phase [5]. We tested the ability of
clb5 clb6 mutants to execute the S-phase checkpoint by
monitoring a biochemical marker of the DNA damage
response and by FACS measurement of S-phase progres-
sion in MMS-treated cells. Phosphorylation of Rad53 is a
critical event following DNA damage and is required for
the delay of S-phase progression [6]. As shown by shifts in
mobility on acrylamide gels, Rad53 was phosphorylated in
all strains following MMS treatment (Figure 2a). Further-
more, FACS analysis showed that both wild-type and clb5
clb6 mutants synchronized in G1 and released into media
containing MMS took longer to reach a 2N DNA content
than similar strains not exposed to MMS (Figure 2b).
Together, these results provide evidence that, despite
their normal function as regulators of DNA replication,
Clb5 and Clb6 are not essential for proper execution of the
S-phase checkpoint.
We next tested whether clb5 clb6 mutants were able to
arrest normally at metaphase following MMS treatment.
Cells synchronized at G1 were released into MMS and
scored for nuclear division. Whereas wild-type strains
arrested as large-budded cells with a short spindle and
rarely underwent nuclear division, approximately 50% of
the clb5 clb6 mutants underwent nuclear division and
anaphase spindle elongation (Figure 3a,b). Approximately
50% of the nuclear divisions that occurred in clb5 clb6
mutants occurred within the mother or daughter cell,
reflecting a spindle-positioning defect previously observed
in clb5 clb6 mutants [7,8]. As might be expected, clb5 clb6
mutants dividing despite the presence of DNA damage
displayed unequal nuclear division and aberrant anaphase
spindle structures (Figure 3c). Single clb5 mutants or clb5
clb6 mutants containing CLB5 on a single copy plasmid
did not undergo nuclear division in the presence of MMS
(Figure 3a, and data not shown). To determine if the pre-
mature nuclear division phenotype accurately represented
a defect in sister chromatid separation, we repeated the
experiment using sister chromatids marked near the cen-
tromere with a GFP tag [9]. In wild-type cells, sister chro-
matids remained together for up to 4 hours following the
release of G1 cells into MMS. In clb5 clb6 mutants exposed
to MMS, however, sister chromatids separated within
90 minutes following release from MMS (Figure 3d).
These data indicate that Clb5 and Clb6 act together
during exposure to DNA damage to maintain sister chro-
matid cohesion during metaphase arrest  induced by the
DNA damage checkpoint.
Arrest at metaphase following DNA damage requires
accumulation of the anaphase inhibitor Pds1 [10–12]. We
tested the possibility that clb5 clb6 mutants could not
arrest at metaphase because they do not accumulate Pds1.
Pds1 levels were not significantly different in wild-type
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Figure 2
The S-phase checkpoint is activated in clb5∆ clb6∆ mutants.
(a) Rad53 is phosphorylated following MMS treatment. Mid-log
cultures of each strain were treated with 0.05% MMS for 30 min.
Immediately following MMS treatment, cells were frozen and whole cell
extracts prepared. Western analysis was performed using anti-Rad53
antibody. (b) Extended delay of S-phase progression in clb5∆ clb6∆
mutants exposed to MMS. Cultures of wild-type (WT) or clb5∆ clb6∆
mutants were arrested in G1 using 100 ng/ml α-factor for 2.5 h. Cells
were washed 3X in fresh media and then released into either media or
media + 0.05% MMS. At each time point cells were fixed in 70%
EtOH and prepared for FACS analysis to determine DNA content. All
data are representative of at least three separate experiments.
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Figure 1
Clb5 and Clb6 are required for checkpoint
function following DNA damage. (a) Strains
lacking Clb5 and Clb6 together are
hypersensitive to MMS treatment. Open
squares, wild type (WT); open circles, clb6∆;
closed triangles, clb5∆; open triangles, clb5∆
clb6∆; closed squares mec1-1. (b) Exogenous
Clb5 rescues the MMS hypersensitivity of
clb5∆ clb6∆ mutants. Open squares, wild
type; open circles, clb5∆ clb6∆; closed
triangles, clb5∆ clb6∆ + pCLB5. (c) clb5∆
clb6∆/clb5∆ clb6∆ diploids are hypersensitive
to MMS. Open squares, wild type; open
circles, clb5∆ clb6∆/clb5∆ clb6∆; closed
triangles, clb5∆ clb6∆/clb5∆ clb6∆ + pCLB5.
(d) Nocodazole treatment partially rescues the
MMS hypersensitivity of clb5∆ clb6∆ mutants.
Cultures arrested in G1 with 100 ng/ml α-
factor were released into 10 µg/ml nocodazole
(NZ) before MMS exposure. Following 20 min
MMS treatment, cells were washed three
times with fresh media before plating for
viability. Open squares, wild type; open circles,
clb5∆ clb6∆; closed triangles, clb5∆
clb6∆ + NZ. All graphs are representative of
at least three separate experiments.
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and clb5 clb6 strains exposed to MMS (Figure 4a). Pds1
accumulated with the same kinetics following release
from G1 and remained present at similar levels in both
strains throughout the experiment. This suggests that in
clb5 clb6 mutants Pds1 is unable to inhibit sister chro-
matid separation. To test this hypothesis and to exclude
the possibility that there were small changes in Pds1
levels, we tested the effect of non-degradable Pds1
expression in clb5 clb6 mutants (Figure 4b). Wild-type and
clb5 clb6 mutants were arrested at G1, induced to express
non-degradable GFP-tagged Pds1, and then released
from the α-factor arrest. The expression of this form
of Pds1 was monitored by following GFP-associated
immunofluorescence. Wild-type cells expressing non-
degradable GFP–Pds1 arrested with unseparated nuclei,
consistent with previous reports [10] (Figure 4b). In con-
trast, clb5 clb6 cells expressing non-degradable GFP–Pds1
underwent nuclear division with kinetics similar to those
of a non-expressing wild-type strain. (Figure 4b). Together,
these results provide evidence that Pds1 cannot inhibit
nuclear division in the absence of the S-phase cyclins
Clb5 and Clb6. 
Pds1 prevents sister chromatid separation by binding
Esp1, preventing Esp1 activation of Scc1 degradation and
sister chromatid separation [13,14]. Like Pds1, Scc1 levels
were not significantly different in wild-type versus clb5
clb6 mutants synchronized in G1 and released into MMS
(data not shown). To determine if the premature anaphase
observed in clb5 clb6 mutants resulted from a failure of
Scc1 to maintain sister chromatid cohesion, we utilized a
non-degradable form of Scc1 and scored cells for
metaphase arrest. As reported by others, expression of
non-degradable Scc1 arrested wild-type cells at metaphase
([15], and Figure 4c). Expression of non-degradable Scc1
in clb5 clb6 mutants caused a metaphase arrest similar to
that seen for wild-type cells. Thus, Scc1 can inhibit
nuclear division in the absence of Clb5 and Clb6. This
suggests that Clb5 and Clb6 act on, downstream of, or in a
parallel pathway to Pds1, and upstream of Scc1 to induce a
stable metaphase arrest.
Two pathways are thought to induce complete
metaphase arrest following DNA damage [16]. In one
pathway, Pds1 binds Esp1 and prevents its ability to acti-
vate cleavage of the sister chromatid ‘glue’ Scc1 [14].
The other pathway includes RAD53, DUN1, and CDC5
and inhibits sister chromatid separation by an unknown
mechanism [16,17]. How these two pathways work
together to regulate metaphase arrest following DNA
damage is unclear, but they may converge to regulate
SCC1 cleavage. For example, rad53 mutants separate
sister chromatids despite DNA damage, but do not do so
in the presence of non-degradable Pds1, suggesting that
Rad53 inhibition of sister chromatid separation may be
dependent on Pds1 functions [17]. Though the precise
position of Clb5 and Clb6 in this regulatory network is
unclear, one testable model is that these two cyclins
function jointly with Pds1 to regulate Esp1 activation of
Scc1 degradation during a prolonged metaphase arrest.
Whether they do this independently of the Rad53
pathway remains to be determined.
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Figure 3
Clb5 and Clb6 are required for metaphase
arrest following MMS treatment.
(a) Inappropriate nuclear division in clb5∆
clb6∆ mutants exposed to MMS. Left, wild-type
and clb5∆ clb6∆ mutants were arrested in G1
and released into MMS as described in
Figure 2b. At each time point cells were fixed in
70% ethanol, treated with 0.1 mg/ml RNaseA
for 60 min, stained with 16 µg/ml propidium
iodide, and scored for budding and nuclear
division. Circles, wild type; triangles, clb5∆;
squares, clb5∆ clb6. (b) Anaphase spindle
formation in clb5∆ clb6∆ mutants exposed to
MMS. As in (a) except that at each time point
cells were fixed and stained with DAPI and anti-
tubulin. (c) Nuclear and spindle morphology of
wild-type and clb5∆ clb6∆ mutants. Cells
treated as in (b) were photographed 150 min
after G1 release to visualize DNA and tubulin.
(d) Inappropriate sister chromatid separation in
clb5∆ clb6∆ mutants exposed to MMS. Top,
sister chromatid separation analyzed with GFP-
tagged sister chromatids. Wild-type and clb5∆
clb6∆ mutant cells were transformed near the
chromosome IV centromere at the TRP1 locus
with lacO repeats and with a centromeric
plasmid containing the GFP–LacI expression
construct under control of the HIS3 promoter.
Cells were arrested in G1 and treated with
MMS as described in Figure 3a, except that
SD –Leu, –His media was used to maintain the
expression plasmid and to induce expression of
the HIS3 promoter. At each time point after G1
release, cells were scored for budding and the
presence of one or two GFP dots. Two visibly
separated GFP dots were interpreted as
separated chromatids. Circles, wild type;
squares, clb5∆ clb6∆. Bottom, separation of
two sister chromatids within a single cell.
Photograph was taken 150 min after release
from G1. All graphs are representative of at
least three separate experiments. 
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Supplementary material
Supplementary material including methodological details is available at
http://current-biology.com/supmat/supmatin.htm.
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Figure 4
Clb5 and Clb6 are required for Pds1 to inhibit
the metaphase-to-anaphase transition.
(a) Pds1 accumulates normally in clb5∆ clb6∆
mutants following MMS exposure. Strains
were synchronized in G1 and released into
MMS (t = 0) as described in Figure 2b. Pds1
levels were detected using anti-Pds1 antibody.
Loading was determined using anti-tubulin
antibody. WT, wild type. (b) Nuclear division
occurs in clb5∆ clb6∆ mutants despite the
presence of non-degradable Pds1. Wild-type
and clb5∆ clb6∆ mutants were transformed
with a centromeric plasmid containing a
galactose-inducible, non-degradable form of
Pds1 tagged with GFP. Mid-log cultures in
YP + 2% raffinose were arrested for 3.5 h with
100 ng/ml α-factor. During the last hour of
arrest galactose was added to 2% to induce
Pds1 expression. The α-factor was then
washed out and cells were released (t = 0)
into YP + galactose to continue Pds1
expression for another hour, after which
dextrose was added to inhibit expression.
Samples were removed every 30 min, fixed
in 3.7% formaldehyde for 3 min, and stained
with DAPI. Cells that showed strong GFP
signal (> 30% of cells) were scored for
budding and nuclear division. Left, nuclear
division in the clb5∆ clb6∆ mutant despite the
presence of non-degradable Pds1. Circles,
wild-type + non-degradable Pds1; triangles,
clb5∆ clb6∆ + non-degradable Pds1; squares,
wild-type + vector. Right, example of nuclear
division in a GFP-positive clb5∆ clb6∆ strain.
The sample was taken 120 min after release
from α-factor. (c) Non-destructible Scc1
inhibits nuclear division in wild-type and clb5∆
clb6∆ mutants. Procedure was identical to that
described for (b) except that nuclear
morphology was scored using propidium
iodide as in Figure 3a. The strains contained
non-degradable Scc1 under control of the Gal
promoter. Open circles, wild-type + non-
degradable Scc1; filled squares, clb5∆
clb6∆ + non-degradable Scc1; open squares,
clb5∆ clb6∆. All graphs are representative of
at least three separate experiments.
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